Reconciling sentinel node omission with CDK4/6 inhibitor eligibility in HR+/HER2- early breast cancer: a real-world cohort analysis - Kandzi, Jannik Daniel; Englisch, Alexander; Böer, Bettina; Hahn, Markus; Wallwiener, Markus; Volmer, Léa; Brucker, Sara; Hartkopf, Andreas; Engler, Tobias (Clinical breast cancer, 2025)